Barbara Guarino

Bellinzona, TI, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammation.

Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammation.

Journal: mBio

Published: April 13, 2026

Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells.

Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells.

Journal: Journal of hepatology

Published: January 10, 2025

Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses.

Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses.

Journal: Immunity

Published: March 18, 2024

A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification.

A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification.

Journal: Cell

Published: February 28, 2024

Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.

Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.

Journal: Nature

Published: July 05, 2023

Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.

Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.

Journal: bioRxiv : the preprint server for biology

Published: January 30, 2023

Neutralization, effector function and immune imprinting of Omicron variants.

Neutralization, effector function and immune imprinting of Omicron variants.

Journal: Nature

Published: January 17, 2023

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.

Journal: Science (New York, N.Y.)

Published: October 20, 2022

A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.

A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.

Journal: Nature

Published: September 19, 2022

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.

Journal: bioRxiv : the preprint server for biology

Published: June 09, 2022

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains.

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains.

Journal: Nature communications

Published: March 28, 2022

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry.

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry.

Journal: Science (New York, N.Y.)

Published: January 06, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026